Skip to main content
. 2023 May 31;2023(5):CD014513. doi: 10.1002/14651858.CD014513

Yaron 2019.

Study characteristics
Methods A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps
RCT (NA clusters and NA providers), conducted in 1) Referral centre for T1D in the Maccabi Heath Care Services, Raanana, Israel; 2) Physicians and study co‐ordinators in Israel
2 arms: 1. Control (conventional care) (control arm) and 2. Intervention (telemedicine) (intervention arm)
Participants Control arm N: 37
Intervention arm N: 37, NA, NA
Diabetes type: 1
Mean age: 44.07 ± 9.48
% Male: 47.76
Longest follow‐up: 12 months
Interventions Control arm: (conventional care)
1) Promotion of self‐management
Intervention arm: (telemedicine)
1) Case management
2) Electronic patient registry
3) Facilitated relay of clinical information
4) Promotion of self‐management
Outcomes Glycated haemoglobin
Harms
Funding source The study was partially supported by Maccabi Health Services Israel
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Patient's baseline characteristics (selection bias) Low risk The 2 groups did not differ in any of the sociodemographic or clinical characteristics examined. No P values reported.
Patient's baseline outcomes (selection bias) Low risk Although P values are only reported at baseline for HbA1c (P = 0.07), the rest of the values in Table 1 appear similar. However, a very limited number of outcome measures are reported at baseline.
Incomplete outcome data (attrition bias) High risk 6 lost in intervention group (16%) and 1 lost in control group (3%), reasons provided in supplementary figure S2.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias) Low risk Objectively measured outcomes: HbA1c, hypo/hyperglycaemia recorded when transmitted data met required parameters (< 70 mg/dL or > 300 mg/dL).
Selective reporting (reporting bias) Low risk Prospectively registered protocol. Outcomes in protocol match those in published report.
Risk of contamination (other bias) Low risk Only intervention group had access to CareLink system.
Other bias Low risk No evidence of other bias.